MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0038361
Entod Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹308.3 Cr
▲ 8% YoY
Net profit · FY 2025
₹26.76 Cr
Net margin 8.7%
EBITDA · FY 2025
₹39.71 Cr
EBITDA margin 12.9%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.06 Cr
Issued & subscribed
Open charges
₹25.55 Cr
Satisfied ₹22.88 Cr
Company age
45 yrs
Est. 1981
Employees · EPFO
1,092
Provident fund records
About Entod Pharmaceuticals Limited
Data last updated:
Entod Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 October 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1981PLC025529. Its GSTIN is 27AAACE6594N1Z0 (Maharashtra).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.06 Cr. It is led by directors including Kishore Gurudas Masurkar (Whole-Time Director) and Dharmesh Pravin Kharwar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ashirwad Bldg Oppbaoi Masjid S V Rd Bandra (W), Mumbai, Maharashtra, India – 400050.
As per the financials filed for FY 2025, the company reported a revenue of ₹308.3 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹26.76 Cr (net margin 8.7%) and EBITDA of ₹39.71 Cr (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 17% over five years.
The company has about 1,092 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Entod International. As per MCA filings, the company has open charges of ₹25.55 Cr and satisfied charges of ₹22.88 Cr on record. Court records list 15 cases involving the company, including 8 filed by the company and 7 filed against it; 9 cases are pending.
Entod Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0038361). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website entodpharma.com.
Company details
CIN U24230MH1981PLC025529
Registration Number 025529
Incorporation Date 31 October 1981
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0038361
Key People
Kishore Gurudas Masurkar Whole-Time Director Dharmesh Pravin Kharwar Director Vivek Manohar Padgaonkar Director Recognitions & Rankings of Entod Pharmaceuticals
Contact details
Entod Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is entodpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressAshirwad Bldg Oppbaoi Masjid S V Rd Bandra (W), Mumbai, Maharashtra, India – 400050
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Entod Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Entod Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Entod Pharmaceuticals operates one associated brand: Entod International. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of product for ophthalmic, ENT and pediatric indications | entodpharma.com |
Business activity
The main business activity of Entod Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Entod Pharmaceuticals Limited, buy the company report.
Financials of Entod Pharmaceuticals Limited
FY 2025 filings availableEntod Pharmaceuticals Limited reported revenue of ₹308.3 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹308.3 Cr ▲ 8%
Net profit · FY 2025
₹26.76 Cr margin 8.7%
EBITDA · FY 2025
₹39.71 Cr margin 12.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 18%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 23%
5 years · compounded
▲ 37%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 8% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.76 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | 8.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Entod Pharmaceuticals Limited, buy the company report.
Board of directors of Entod Pharmaceuticals Limited
Entod Pharmaceuticals has 7 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmesh Pravin Kharwar | Director | 20 Aug 2024 | 2 Years 2 Months | Current |
| Vivek Manohar Padgaonkar Also directs: Paddy Advisory Services LLP, Bervin Investment and Leasing Limited, Martin and Harris Laboratories Limited and 1 more | Director | 29 Jul 2024 | 2 Years 2 Months | Current |
| Kishore Gurudas Masurkar Also directs: Shoma Farms Private Limited, Medisearch Laboratories (Bombay) Private Limited, Entod Healthcare Private Limited and 1 more | Whole-Time Director | 31 Oct 1981 | 44 Years 11 Months | Current |
| Vivek Rajendra Shete | Director | 15 Jan 2022 | 4 Years 9 Months | Current |
| Rita Kishore Masurkar Also directs: Medisearch Laboratories (Bombay) Private Limited, Entod Healthcare Private Limited, Matanand Welfare Foundation and 1 more | Director | 01 Oct 2011 | 15 Years 0 Months | Current |
| Vinay Gurudas Masurkar | Director | 25 Sep 2009 | 17 Years 0 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Entod Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eastern Agencies Healthcare Private Limited | ₹324.45 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Sneha Medicare Private Limited | ₹316.29 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Entod Pharmaceuticals Limitedthis company | ₹308.3 Cr (FY 2025) | ₹26.76 Cr | 8.7% | 8.0% | 1,092 | Mumbai, Maharashtra, India |
| Chhattisgarh Medical Services Corporation Limited | ₹305.27 Cr (FY 2019) | 17.0% | Raipur, Chhattisgarh, India | |||
| Magnet Labs Private Limited | ₹300.67 Cr (FY 2022) | 20.0% | New Delhi, Delhi, India | |||
| Lazz Medico Private Limited | ₹300.3 Cr (FY 2025) | 40.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Entod Pharmaceuticals Limited, buy the company report.
Auditor
Entod Pharmaceuticals Limited is audited by Nadkarni Date & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nadkarni Date & Associates LLP | FY 2023 | W100596 |
Shareholding
The shareholding of Entod Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Entod Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹25.55 Cr
Satisfied charges
₹22.88 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2025 | 101163526 | Others | ₹54.82 Lakh | Open | |
| 04 Aug 2025 | 101133834 | Others | ₹25 Cr | Open | |
| 24 Jun 2021 | 100465566 | Hdfc Bank Limited | ₹60 Lakh | Satisfied | |
| 09 Mar 2021 | 100431985 | Others | ₹11 Lakh | Satisfied | |
| 15 Nov 2017 | 100139811 | Others | ₹30 Lakh | Satisfied |
To see the full charge records of Entod Pharmaceuticals Limited, buy the company report.
Total charge records: 25 View all charges
Legal cases
Entod Pharmaceuticals Limited has 15 court cases on record: 8 filed by Entod Pharmaceuticals, 7 filed against it. 9 cases are pending and 6 are disposed.
Total cases
15
Filed by the company
8
Filed against the company
7
Pending
9
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 7 | 9 |
| District courts | 1 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Alliance Pharmaceuticals Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Alliance Pharmaceuticals Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed against the company by Alliance Pharmaceuticals Limited Through Sudarshana Sen-Mitra | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Micro Labs Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed by the company against Alliance Pharmaceuticals Limited | Pending |
To see the full case history of Entod Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Entod Pharmaceuticals Limited has 9 MSME Form 1 returns on record between 2018 and 2023, listing 747 overdue payments to 61 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 61)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Saf Scientific Chemicals Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Entod Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Entod Pharmaceuticals has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Entod Pharmaceuticals Limited has a workforce of 1,092 employees on its EPFO records as of Apr 25, 2024, across 1 active EPFO establishment.
Employee count
1,092
Active EPFO establishments
1
Employee growth
17.67%
GST
Entod Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE6594N1Z0 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Entod Pharmaceuticals Limited, buy the company report.
Recent activity
Entod Pharmaceuticals Limited has 20 board changes on record since 1981: 7 appointments and 13 cessations. The latest: Dharmesh Pravin Kharwar ceased to be Additional Director on 29 Sep 2024.
Charges
A charge registered on 13 Oct 2016 via Charge ID 100057531 with Hdfc Bank Limited was fully satisfied on 25 Nov 2025.
AGM
Entod Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.55 Cr with Charge ID 101163526 was registered on 23 Sep 2025.
Charges
A charge registered on 09 Mar 2021 via Charge ID 100431985 with Others was fully satisfied on 07 Aug 2025.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101133834 was registered on 04 Aug 2025.
Filing
Entod Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Dharmesh Pravin Kharwar ceased to be Additional Director.
Ceased
Vivek Manohar Padgaonkar ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 13.00 Cr registered on 13 Oct 2016 with Charge ID 100057531 was modified on 28 Aug 2024.
Appointed
Dharmesh Pravin Kharwar was appointed as Director.
Appointed
Vivek Manohar Padgaonkar was appointed as Director.
Charges
A charge registered on 15 Nov 2017 via Charge ID 100139811 with Others was fully satisfied on 27 Jun 2023.
62 earlier events are in the company report.
Frequently asked questions
Entod Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 October 1981 (45+ years old) and is registered under CIN U24230MH1981PLC025529.
Entod Pharmaceuticals has 7 current directors:
- Kishore Gurudas Masurkar - Whole-Time Director
- Dharmesh Pravin Kharwar - Director
- Vivek Manohar Padgaonkar - Director
- Vivek Rajendra Shete - Director
- Rita Kishore Masurkar - Director
- Vinay Gurudas Masurkar - Director
- Nikhil Kishore Masurkar - Director
The latest financial statements of Entod Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Entod Pharmaceuticals is 27AAACE6594N1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Entod Pharmaceuticals is U24230MH1981PLC025529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Entod Pharmaceuticals has 15 court cases on record: 8 filed by the company and 7 filed against it. 9 are pending. Most are in the high courts.
Entod Pharmaceuticals was incorporated on 31 October 1981, making it 45+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Entod Pharmaceuticals by revenue are Eastern Agencies Healthcare Private Limited, Sneha Medicare Private Limited, Chhattisgarh Medical Services Corporation Limited, Magnet Labs Private Limited, Lazz Medico Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Dharmesh Pravin Kharwar ceased to be Additional Director on 29 Sep 2024. Vivek Manohar Padgaonkar ceased to be Additional Director on 29 Sep 2024. Dharmesh Pravin Kharwar was appointed as Director on 20 Aug 2024. Entod Pharmaceuticals has 20 board changes on record in total.
Yes, Entod Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0038361).
Entod Pharmaceuticals has 9 MSME Form 1 returns on record between 2018 and 2023, listing 747 overdue payments to 61 micro and small suppliers. The latest return was filed on 11 Dec 2023.
Entod Pharmaceuticals can be reached through the website entodpharma.com. Its registered office is in Mumbai, Maharashtra, India.